The global pharmaceutical industry was valued at USD$1.25T in 2019 and is forecasted to grow to about $1.5T in 2021. Then, Covid-19 happened and threw us a curveball that will likely impact all existing forecasts. Since the outbreak, retail of over-the-counter drugs spiked before lockdowns in March 2020 as consumers stockpiled these drugs. Conversely, hospitals are expected to experience lower growth rates in 2020 as they shift their focus and resources to the Covid-19 battle, reducing their capabilities to keep up with regular patient care. Although the situation in Singapore has more or less stabilised, the world at large is still struggling to manage the pandemic outbreak. It may be prudent to approach all forecasts with a wider range of variance. That said, global healthcare spending is likely to remain stable. The pandemic has forced the pharmaceutical industry to evolve quickly in the past few months, and this shift has caught the attention of investors like